ICI rechallengemccRCCnivolumabpembrolizumabcabozantiniblenvatinibipilimumabaxitinib
…5) (figure 1).Conclusions Our results outline opportunities for ICI rechallenge, regardless of the prior immunotherapy administered. Improved o…
4articles mentioning treatments
15treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: ICI rechallenge ×
ICI rechallenge
This treatment is selected. Its supporting articles are shown below.
Articles mentioning ICI rechallenge
4 articles · page 1 of 1ICI rechallengemelanomacancerICIs
…s following initial ICI therapy (26% and 23%, respectively) and ICI rechallenge (31% and 29%, respectively). The adjuvant, palliative, and neoa…
locoregional therapyICI rechallengeThe First Affiliated Hospital of Nanchang UniversitySun Yat-sen University Cancer Center Institutional Review Boardrecurrent or metastatic nasopharyngeal carcinoma (RM-NPC)
…p=0.035), EBV DNA level (HR 1.743, 95%CI 1.252-2.426, p=0.001), locoregional therapy (HR 0.467, 95%CI 0.268-0.812, p=0.007), and rechallenge with an…
ICI rechallengenccRCCICImetastatic non-clear cell renal cell carcinomaICI-rechallenge
… to investigate the efficacy, safety, and predictive markers of ICI rechallenge in this population.Methods 39 patients with metastatic nccRCC w…